Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXDO6N
|
||||
| Drug Name |
(S)-1-(1H-Indol-4-yloxy)-3-[4-(3-methyl-benzo[b]thiophen-2-yl)-piperidin-1-yl]-propan-2-ol
|
||||
| Synonyms |
CHEMBL299485
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C25H28N2O2S
|
||||
| Canonical SMILES |
Cc1c(sc2ccccc12)C3CCN(C[C@H](O)COc4cccc5[nH]ccc45)CC3
|
||||
| InChI |
InChI=1S/C25H28N2O2S/c1-17-20-5-2-3-8-24(20)30-25(17)18-10-13-27(14-11-18)15-19(28)16-29-23-7-4-6-22-21(23)9-12-26-22/h2-9,12,18-19,26,28H,10-11,13-16H2,1H3/t19-/m0/s1
|
||||
| InChIKey |
PNPVRCVLTPANGP-IBGZPJMESA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.